Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast
US10092541B2 · kind B2 · utility
3Cited by
26References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 13, 2015 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Aug 13, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating, managing or preventing diseases ameliorated by inhibiting PDE4 such as psoriasis, ankylosing spondylitis, Behcet's disease, rheumatoid arthritis, atopic dermatitis, Crohn's disease, and ulcerative colitis are disclosed. Specific methods encompass the administration of apremilast in specific dosage titration schedule, alone or in combination with a second active agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.